Association of Aortic Valve Sclerosis and Coronary Artery Disease in Patients with Severe Nonischemic Mitral Regurgitation

Clinical Cardiology

Volumn 26, Issue 12, 2003, Pages 579-582

  Rossi, Andrea ^a   Bertagnolli, Gerald ^a   Cicoira, Mariantonietta ^a   Golia, Giorgio ^a   Zanolla, Luisa ^a   Santini, Francesco ^a   Cemin, Claudio ^b   Ferrario, Gabriele ^b   Zardini, Piero ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Rehabilitation Center Eremo   (Italy)

Author keywords

Aortic valve sclerosis; Coronary atherosclerosis; Mitral regurgitation

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA VALVE STENOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART MUSCLE ISCHEMIA; HEART SURGERY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; MORTALITY; PREDICTION; PREOPERATIVE EVALUATION; SEX RATIO;

EID: 0344395109     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960261207     Document Type: Article

References (32)

1. American Heart Association Heart and Stroke Facts: 1996 statistical supplements. Dallas, Texas: American Heart Association, 1996
2. Freedman DS, Wattingnei WA, Srinivasan S, Newman WA III, Tracy RE, Byers T, Berenson GS: The relation of atherosclerotic lesions to antemortem and postmortem lipid levels: The Bogalusa Heart Study. Atherosclerosis 1993;104:37-46
3. Feinleib M, Kannel WB, Tedeschi CG, Landau TK, Garrison RJ: The relation ofantemortem characteristics to cardiovascular findings at necroscopy: The Framingham Study. Atherosclerosis 1979;34:145-157
4. Ramsdale DR, Bennett DH, Bray L, Ward C, Beton DC, Faragher EB: Angina, coronary risk factors and coronary artery disease in patients with valvular disease. A prospective study. Eur Heart J 1984;5:716-726
5. Chaitman BR, Bourassa MG, Davis K, Rogers WJ, Tyras DH, Berger R, Kennedy JW, Fisher L, Judkins MP, Mock MB, Killip T: Angiographic prevalence of high risk coronary artery disease in patient subsets (CASS). Circulation 1981;64:360-367
6. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS: Association of aortic valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:142-147
7. Carabello B: Editorial: Aortic sclerosis-A window to the coronary arteries? N Engl J Med 1999;341(3):193-194
8. Wierzbicki A, Shetty C: Aortic stenosis: An atherosclerotic disease? J Heart Valve Dis 1999;8:416-423
9. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD: Characterization of the early lesion of degenerative valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994;90:844-853
10. Olsson M, Rosenqvist M, Nilsson J: Expression of HDA-DR antigen and smooth muscle cell differentiation markers by valvular fibroblasts in degenerative aortic stenosis. J Am Coll Cardiol 1994;24:1664-1671
11. O'Brien KD, Kuuisto J, Reichenbach DD, Ferguson M, Giachelli C, Alpers CE, Otto CM: Osteopontin is expressed in human aortic valvular lesions. Circulation 1995;92:2163-2168
12. Olsson M, Dalsgaad CJ, Haegerstrand A, Rosenqvist M, Ryden L, Nilsson J: Accumulation of T-lymphocytes and expression of interleukin 2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1994;23:1162-1170
13. Mohler ER: Editorial: Are atherosclerotic processes involved in aortic valve calcification? Lancet 2000;356:524-525
14. Deutscher S, Rockette HE, Krishnaswami V: Diabetes and hypercholesterolemia among patients with calcific aortic stenosis. J Chronic Dis 1984; 37:407-415
15. Hoagland PM, Cook EF, Flatley M, Walker C, Goldman L: Case control analysis of risk factors for presence of aortic stenosis in adults (age 50 years or older). Am J Cardiol 1985;55:744-747
16. Mohler ER, Sheridan MJ, Nichols R, Harvey WP, Waller BF: Development and progression of aortic valve stenosis: Atherosclerotic risk factors-a causal relationship? A clinical morphologic study. Clin Cardiol 1991;14: 995-999
17. Stewart BF, Siscovick D, Bonnie K, Lind MS,Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM: Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol 1997;29(3):630-634
18. Tribouilloy C, Shen WF, Peltier M, Lesbre JP: Noninvasive prediction of coronary artery disease by transesophageal echocardiographic detection of thoracic aortic plaque in valvular heart disease. Am J Cardiol 1994;74: 258-260
19. Parthenakis F, Skalidis E, Simantirakis E, Kounali D, Vardas P, Nihoyannopoulos P: Absence of atherosclerotic lesions in the thoracic aorta indicates absence of significant coronary artery disease. Am J Cardiol 1996;77: 1118-1121
20. Adler Y, Levinger U, Koren A, Tanne D, Fink N, Vaturi M, Iakobishvili Z, Battler A, Zelikovski A, Sagie A: Relation of nonobstructive aortic valve calcium to carotid arterial atherosclerosis. Am J Cardiol 2000;86:1102-1105
21. Adler Y, Shohat-Zabarski R, Vaturi M, Shapira Y, Ehrlich S, Jortner R, Assali A, Zonshin A, Sagie A: Association between mitral annular calcium and aortic atheroma as detected by transesophageal echocardiographic study. Am J Cardiol 1998;81:784-786
22. Sochor H: Technetium-99m sestamibi in chronic coronary artery disease: The European experience. Am J Cardiol 1990;66:91E-96E
23. Maddahi J, Kiat H, Van Train KF, Prigent F, Friedman J, Garcia EU, Alazrakin N, DePuey EG, Nichols K, Berman DS: Myocardial perfusion imaging with technetium 99m sestamibi SPECT in the evaluation of coronary artery disease. Am J Cardiol 1990;66:55E-62E
24. Lee LY, Pellikka PA, McCully DW, Mahoney DW, Seward JB: Nonexercise stress transthoracic echocardiography: Transesophageal atrial pacing versus dobutamine stress. J Am Coll Cardiol 1999;33:506-511
25. Chuah SC, Pellikka PA, Roger VL, McCully RB, Seward JB: Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation 1998;97:1474-1480
26. Shavelle DM, Budoff MJ, LaMont DH, Shavelle RM, Kennedy JM, Brundage BH: Exercise testing and electron beam computed tomography in the evaluation of coronary artery disease. J Am Coll Cardiol 2000;36:32-38
27. Lee TH, Boucher CA: Noninvasive tests in patients with stable coronary artery disease. N Engl J Med 2001;344:1840-1845
28. Gibbons RJ, Chatterjee K, Daley J, Douglas JF, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O'Rourke RA, Schafer WP, Williams SV, Ritchie TL, Cheitlin MD, Eagle KA, Gardner TJ, Garson A Jr, Russell RD, Ryan TJ, Smith SC Jr: Guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 1999;33:2092-2197
29. Hak AE, Pols HA, van Hemert AM, Hofman A, Witteman JC: Progression of aortic calcification is associated with metacarpal bone loss during menopause: A population-based longitudinal study. Arterioscler Thromb Vasc Biol 2000;20(8):1926-1931
30. Maher ER, Zoung G, Smyth-Walsh B, Pugh S, Curtis JR: Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 1987;2 (8564):875-877
31. Huting J: Progression of valvular sclerosis in end-stage renal disease treated by long-term peritoneal dialysis. Clin Cardiol 1992;15:745-750
32. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV: Valvular heart disease associated with fenfluramine-phetermine. N Engl J Med 1997;337:581-588